![© Getty Images](/var/wrbm_gb_food_pharma/storage/images/_aliases/wrbm_large/publications/pharmaceutical-science/outsourcing-pharma.com/news/clinical-development/cure51-co-founders-on-changing-cancer-treatment/17615263-1-eng-GB/Cure51-co-founders-on-changing-cancer-treatment.jpg)
How Cure51’s AI breakthroughs are turning cancer into a manageable disease – an insider’s look
Discover the groundbreaking work of Cure51, co-founded by Nicolas Wolikow and Simon Istolainen, revolutionizing cancer treatment through advanced AI and biotechnology.